Tradestie Institutional Equity Comparison Engine
ECOR vs DARE โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DARE Overall Edge
DARE Captures Institutional Edge (2โ1 Pillars ยท 6โ4 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Dare Bioscience, Inc. Common Stock (DARE) driven by superior Valuation, Growth & Margin while ECOR counters with relative strength in Momentum & Technical. Fundamentally, ECOR trades at N/M Forward P/E with -33.1% operating margin (+11.5% YoY revenue) versus DARE at 1.3x Forward P/E and -746.1% operating margin (+2005.6% YoY). In options structure, ECOR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against DARE sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
DARE
ECOR N/M vs DARE 1.3x Fwd P/E
Growth & Margin Winner
DARE
Op Margin -33.1% vs -746.1% ยท YoY +11.5% vs +2005.6%
Momentum & Technical Winner
ECOR
1Y -4.0% vs -74.6% ยท 52W Pos 6% vs 1%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ECOR
NASDAQ
electroCore, Inc. Common Stock
Electromedical & Electrotherapeutic Apparatus
$4.85
-6.19% 1D
Market Cap
$47.7M
1M Return
-34.01%
1Y Return
-3.96%
Forward P/E
N/M
Unified AI Score
56.8 / 100
HOLD
Tech 68.0
Fund 53.0
Flow 50.0
Mom 64.0
DARE
NASDAQ
Dare Bioscience, Inc. Common Stock
Pharmaceutical Preparations
$0.45
+0.44% 1D
Market Cap
$8.8M
1M Return
-34.3%
1Y Return
-74.61%
Forward P/E
1.3x
Unified AI Score
43.1 / 100
HOLD
Tech 35.0
Fund 46.0
Flow 50.0
Mom 55.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ECOR -3.96%
DARE -74.61%
Spread: +70.65 pp (ECOR Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | ECOR Revenue | DARE Revenue | ECOR Op. Margin | DARE Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $0M | N/A | -5494.1% | N/A | ECOR |
| FY2019 | $0M | N/A | -1928.2% | N/A | ECOR |
| FY2020 | $0M | N/A | -707.9% | N/A | ECOR |
| FY2021 | $10M | N/A | -367.7% | N/A | ECOR |
| FY2022 | $10M | $10M | -266.2% | -313.9% | ECOR |
| FY2023 | $20M | $0M | -120.2% | -1101.9% | ECOR |
| FY2024 | $30M | $0M | -48.3% | -239692.2% | ECOR |
| FY2025 | $30M | $0M | -41.1% | -1315.5% | ECOR |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ECOR | DARE | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $47.7M | $8.8M | Larger Scale | ECOR |
| Trailing P/E Ratio Valuation | N/M | 1.3x | Lower Multiple | DARE |
| Forward P/E Ratio Valuation | N/M | 1.3x | Lower Multiple | DARE |
| Revenue Growth (YoY) Growth | +11.5% | +2005.6% | Higher Growth | DARE |
| Operating Margin (TTM) Profitability | -33.1% | -746.1% | Higher Margin | ECOR |
| Net Profit Margin Profitability | -33.5% | 0.0% | Higher Margin | DARE |
| Return on Equity (ROE) Capital Efficiency | -478.7% | -407.1% | Higher ROE | DARE |
| 52-Week Range Position Momentum | 6% ($4โ$13) | 1% ($0โ$4) | Stronger Trend | ECOR |
| Beta / 30D Volatility Risk Regime | 1.52ฮฒ ยท 155% Vol | 1.52ฮฒ ยท 112% Vol | Lower Realized Risk | DARE |
| Unified Institutional Score Composite Signal | 56.8 / 100 (HOLD) | 43.1 / 100 (HOLD) | Higher Composite | ECOR |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ECOR vs DARE Buy Guide
ECOR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
DARE
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ECOR nor DARE registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.